IGF1 and adenoma: The IGF‐1 per cent reduction after 3 and 6 months of SSAs treatment was also significantly lower when we compared adenomas with low (score 1) and moderate/high (scores 2 and 3) SSTR2 expression (P = 0.001 and 0.003, respectively).